Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 4
2002 3
2004 5
2005 4
2006 8
2007 5
2008 8
2009 11
2010 10
2011 24
2012 19
2013 9
2014 14
2015 9
2016 16
2017 14
2018 15
2019 24
2020 26
2021 25
2022 29
2023 27
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

273 results

Results by year

Filters applied: . Clear all
Page 1
Ovarian Cancer: An Integrated Review.
Stewart C, Ralyea C, Lockwood S. Stewart C, et al. Semin Oncol Nurs. 2019 Apr;35(2):151-156. doi: 10.1016/j.soncn.2019.02.001. Epub 2019 Mar 11. Semin Oncol Nurs. 2019. PMID: 30867104 Review.
OBJECTIVE: To provide an overview of the risk factors, modifiable and non-modifiable, for ovarian cancer as well as prevention, diagnostic, treatment, and long-term survivorship concerns. ...
OBJECTIVE: To provide an overview of the risk factors, modifiable and non-modifiable, for ovarian cancer as well as prevention …
Epidemiology of Triple-Negative Breast Cancer: A Review.
Howard FM, Olopade OI. Howard FM, et al. Cancer J. 2021 Jan-Feb 01;27(1):8-16. doi: 10.1097/PPO.0000000000000500. Cancer J. 2021. PMID: 33475288 Review.
However, preventive and screening strategies remain tailored to the demographics of less lethal luminal cancers. This review examines the ethnic, genetic, and modifiable risk factors associated with triple-negative breast cancer, which providers must recognize to address t …
However, preventive and screening strategies remain tailored to the demographics of less lethal luminal cancers. This review examines the et …
European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer.
Vergote I, González-Martín A, Ray-Coquard I, Harter P, Colombo N, Pujol P, Lorusso D, Mirza MR, Brasiuniene B, Madry R, Brenton JD, Ausems MGEM, Büttner R, Lambrechts D; European experts’ consensus group. Vergote I, et al. Ann Oncol. 2022 Mar;33(3):276-287. doi: 10.1016/j.annonc.2021.11.013. Epub 2021 Dec 1. Ann Oncol. 2022. PMID: 34861371 Free article. Review.
The collaborative European experts' consensus group consisted of a steering committee (n = 14) and contributors (n = 84). A (modified) Delphi process was used to establish consensus statements based on a systematic literature search, conducted according to the Preferred Re …
The collaborative European experts' consensus group consisted of a steering committee (n = 14) and contributors (n = 84). A (modified …
Break-induced replication orchestrates resection-dependent template switching.
Zhang T, Rawal Y, Jiang H, Kwon Y, Sung P, Greenberg RA. Zhang T, et al. Nature. 2023 Jul;619(7968):201-208. doi: 10.1038/s41586-023-06177-3. Epub 2023 Jun 14. Nature. 2023. PMID: 37316655 Free PMC article.
Furthermore, the SNM1A nuclease was identified as the major effector of ubiquitinated PCNA-dependent DNA damage tolerance. SNM1A recognizes the ubiquitin-modified break-induced replisome at damaged telomeres, and this directs its nuclease activity to promote resection. ...
Furthermore, the SNM1A nuclease was identified as the major effector of ubiquitinated PCNA-dependent DNA damage tolerance. SNM1A recognizes …
Machine learning reveals genetic modifiers of the immune microenvironment of cancer.
Riley-Gillis B, Tsaih SW, King E, Wollenhaupt S, Reeb J, Peck AR, Wackman K, Lemke A, Rui H, Dezso Z, Flister MJ. Riley-Gillis B, et al. iScience. 2023 Aug 9;26(9):107576. doi: 10.1016/j.isci.2023.107576. eCollection 2023 Sep 15. iScience. 2023. PMID: 37664640 Free PMC article.
Here, we developed a machine learning approach to map iTME modifiers within loci from genome-wide association studies (GWASs) for breast cancer (BrCa) incidence. ...Two of the top ranking BrCa candidates, LSP1 and TLR1, were orthogonally validated as iTME …
Here, we developed a machine learning approach to map iTME modifiers within loci from genome-wide association studies (GWASs) for bre …
New treatment options for hormone receptor positive breast cancer in 2023.
Lüftner D. Lüftner D. Curr Opin Obstet Gynecol. 2023 Feb 1;35(1):62-66. doi: 10.1097/GCO.0000000000000834. Epub 2022 Nov 7. Curr Opin Obstet Gynecol. 2023. PMID: 36341983 Review.
PURPOSE OF REVIEW: Hormone receptor positive, human epidermal growth factor receptor 2 negative (HR+/HER2-) breast cancer does respond to chemotherapy but can be addressed with a better therapeutic index by using biologically modified endocrine therapy. The most pronounced …
PURPOSE OF REVIEW: Hormone receptor positive, human epidermal growth factor receptor 2 negative (HR+/HER2-) breast cancer does respond to ch …
Review of the literature on combined oral contraceptives and cancer.
Kamani M, Akgor U, Gültekin M. Kamani M, et al. Ecancermedicalscience. 2022 Jun 23;16:1416. doi: 10.3332/ecancer.2022.1416. eCollection 2022. Ecancermedicalscience. 2022. PMID: 36072240 Free PMC article. Review.
We aimed to review the accumulated knowledge to date to appreciate the modifying effects combined oral contraceptives may have on carcinogenesis. ...Although studies do not clearly support increased risk with COC use in high-risk groups, such as women with family history o …
We aimed to review the accumulated knowledge to date to appreciate the modifying effects combined oral contraceptives may have on car …
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study.
Colombo N, Gadducci A, Landoni F, Lorusso D, Sabbatini R, Artioli G, Berardi R, Ceccherini R, Cecere SC, Cormio G, De Angelis C, Legge F, Lissoni A, Mammoliti S, Mangili G, Naglieri E, Petrella MC, Ricciardi GRR, Ronzino G, Salutari V, Sambataro D, Savarese A, Scandurra G, Tasca G, Tomao F, Valabrega G, Zavallone L, Pignata S. Colombo N, et al. Gynecol Oncol. 2023 Aug;175:182-189. doi: 10.1016/j.ygyno.2023.05.065. Epub 2023 Jun 22. Gynecol Oncol. 2023. PMID: 37355448
Based on scientific evidences, the board produced practice-oriented statements. Consensus was reached via a modified Delphi study that involved a panel of 22 experts from across Italy. RESULTS: Twenty-seven evidence- and consensus-based statements are presented, covering t …
Based on scientific evidences, the board produced practice-oriented statements. Consensus was reached via a modified Delphi study tha …
The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S, Yim S, Park H. Chang S, et al. Exp Mol Med. 2019 Jun 20;51(6):1-17. doi: 10.1038/s12276-019-0230-6. Exp Mol Med. 2019. PMID: 31221981 Free PMC article. Review.
Table 1 Cancer driver genes involved in epigenetics Pathways involved in epigenetics Driver genes Tumor suppressor/oncogene prediction (by 20/20+(a)) Approved name Activity Cancer type(b) Other driver genes in this pathways Histone modification KDM6A tsg Lysine demethylase 6A, UT …
Table 1 Cancer driver genes involved in epigenetics Pathways involved in epigenetics Driver genes Tumor suppressor/oncogene prediction (by 2 …
Modifiable risk factors in women at high risk of breast cancer: a systematic review.
Cohen SY, Stoll CR, Anandarajah A, Doering M, Colditz GA. Cohen SY, et al. Breast Cancer Res. 2023 Apr 24;25(1):45. doi: 10.1186/s13058-023-01636-1. Breast Cancer Res. 2023. PMID: 37095519 Free PMC article. Review.
For women with BRCA mutations, most studies reported no association between modifiable risk factors and BC; however, some observed increased (smoking, MHT/HC, body mass index (BMI)/weight) and decreased risk (alcohol, smoking, MHT/HC, BMI/weight, physical activity). …
For women with BRCA mutations, most studies reported no association between modifiable risk factors and BC; however, some obse …
273 results